|
The Immunohistochemistry Antibody Company
|
|
|
Lymphoma Screen 31 Tissue Microarray - LS-SLYCA31This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SLYCA31 |
| Product Name: | Lymphoma Screen 31 |
| Description: | Myeloma lymphoma and normal/non-neoplastic specimens |
| Format: | FFPE |
| Category: | Human Tumor and Normal |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | No |
| Core Diameter: | 2 mm |
| Core Thickness: | 5 µm |
| Cases: | 48 |
| Cores: | 48 |
| Slides Per Set: | 1 |
LS-SLYCA31 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Bone, Cerebral dura mater (Bon); Bone, Clavicle (Bon); Bone, Pubis (Bon); Bone, Rib (Bon); Bone, Sternum (Bon); Bone, Thoracic vertebrae (Bon); Lymph node (Lym); Lymph node, Axilla (Lym); Lymph node, Brain (Lym); Lymph node, Clavicle (Lym); Lymph node, Groin (Lym); Lymph node, Mediastinum (Lym); Lymph node, Neck (Lym); Nasal cavity (Nsl); Pelvic cavity (Pel); Tonsil (Tsl);
LS-SLYCA31 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type |
|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 57 y | Bone, Sternum (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A2 | Human | F | 46 y | Bone, Clavicle (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A3 | Human | M | 62 y | Bone, Rib (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A4 | Human | M | 37 y | Bone, Rib (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A5 | Human | M | 57 y | Bone, Pubis (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A6 | Human | M | 69 y | Bone, Clavicle (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A7 | Human | F | 62 y | Bone, Rib (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | A8 | Human | M | 39 y | Bone, Thoracic vertebrae (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | B1 | Human | M | 44 y | Bone, Cerebral dura mater (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | B2 | Human | M | 64 y | Bone, Clavicle (Bon) | Myeloma, Plasma cell | Malignant |
| 1 | B3 | Human | M | 38 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | B4 | Human | M | 17 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | B5 | Human | F | 37 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | B6 | Human | F | 38 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | B7 | Human | F | 27 y | Lymph node, Clavicle (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | B8 | Human | M | 37 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C1 | Human | F | 36 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C2 | Human | M | 4 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C3 | Human | M | 38 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C4 | Human | M | 65 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C5 | Human | M | 38 y | Lymph node, Groin (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | C6 | Human | F | 27 y | Lymph node, Groin (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | C7 | Human | M | 68 y | Lymph node, Groin (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | C8 | Human | M | 17 y | Lymph node, Brain (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D1 | Human | M | 30 y | Lymph node, Axilla (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D2 | Human | M | 70 y | Lymph node (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D3 | Human | M | 25 y | Lymph node, Neck (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D4 | Human | M | 59 y | Lymph node, Neck (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D5 | Human | F | 56 y | Lymph node, Groin (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D6 | Human | F | 25 y | Lymph node, Neck (Lym) | Diffuse large B cell lymphoma | Malignant |
| 1 | D7 | Human | F | 50 y | Pelvic cavity (Pel) | Burkitt's lymphoma | Malignant |
| 1 | D8 | Human | F | 38 y | Pelvic cavity (Pel) | Burkitt's lymphoma | Malignant |
| 1 | E1 | Human | F | 44 y | Nasal cavity (Nsl) | Burkitt's lymphoma | Malignant |
| 1 | E2 | Human | M | 28 y | Nasal cavity (Nsl) | T cell lymphoma | Malignant |
| 1 | E3 | Human | M | 39 y | Lymph node, Mediastinum (Lym) | T cell lymphoma | Malignant |
| 1 | E4 | Human | M | 40 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | E5 | Human | M | 62 y | Lymph node, Groin (Lym) | T cell lymphoma | Malignant |
| 1 | E6 | Human | M | 36 y | Lymph node, Neck (Lym) | T cell lymphoma | Malignant |
| 1 | E7 | Human | M | 32 y | Lymph node, Groin (Lym) | T cell lymphoma | Malignant |
| 1 | E8 | Human | M | 60 y | Lymph node, Groin (Lym) | T cell lymphoma | Malignant |
| 1 | F1 | Human | M | 38 y | Lymph node, Groin (Lym) | T cell lymphoma | Malignant |
| 1 | F2 | Human | F | 37 y | Tonsil (Tsl) | Follicular B-cell lymphoma | Malignant |
| 1 | F3 | Human | M | 21 y | Lymph node (Lym) | Follicular B-cell lymphoma | Malignant |
| 1 | F4 | Human | F | 35 y | Lymph node, Groin (Lym) | Follicular B-cell lymphoma | Malignant |
| 1 | F5 | Human | M | 35 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | F6 | Human | M | 30 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | F7 | Human | M | 35 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | F8 | Human | M | 40 y | Lymph node (Lym) | Normal | Benign non-neoplastic |